CIK 0001790340 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 0 | 2.1 M | ||
| Net income (USD) | -56.0 M | -53.5 M | -50.5 M | |
| Diluted EPS (USD/shares) | -1.27 | -1.88 | -1.91 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-08-05 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-05 | 8-K | 8-K items 2.02,9.01 | 2026-08-05 |
| 2026-07-28 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-17 | 4 | FORM 4 | 2026-07-16 |
| 2026-07-16 | 3 | FORM 3 | 2026-07-16 |
| 2026-06-24 | 4 | FORM 4 | 2026-06-23 |
| 2026-06-16 | 4 | FORM 4 | 2026-06-15 |
| 2026-06-15 | 8-K | 8-K items 5.02 | 2026-06-11 |
| 2026-06-11 | 4 | FORM 4 | 2026-06-11 |
| 2026-06-11 | 4 | FORM 4 | 2026-06-11 |
| 2026-06-11 | 4 | FORM 4 | 2026-06-11 |
| 2026-06-11 | 4 | FORM 4 | 2026-06-11 |
| 2026-06-11 | 4 | FORM 4 | 2026-06-11 |
| 2026-06-11 | 8-K | 8-K items 5.07 | 2026-06-11 |
| 2026-06-01 | 8-K | 8-K items 8.01 | 2026-06-01 |
| 2026-05-15 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-15 | 8-K | 8-K items 2.02,9.01 | 2026-05-15 |
| 2026-04-20 | DEFA14A | DEFA14A | |
| 2026-04-20 | DEF 14A | DEF 14A | 2026-04-20 |
| 2026-03-17 | 4 | FORM 4 | 2026-03-13 |
| 2026-03-06 | 10-K | 10-K | 2025-12-31 |
| 2026-03-06 | 8-K | 8-K items 2.02,9.01 | 2026-03-06 |
| 2026-02-05 | 4 | FORM 4 | 2026-02-03 |
| 2026-02-05 | 4 | FORM 4 | 2026-02-03 |
| 2026-02-05 | 4 | FORM 4 | 2026-02-03 |
Forms on file (last 1,000): 4 143, 8-K 45, 3 18, SC 13G/A 18, 10-Q 16, CORRESP 8, SC 13G 7, 424B5 6. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=IMRX (0.002 USD), /gw/filings/filings?ticker=IMRX&form=8-K, /gw/filings/facts?ticker=IMRX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange